Drugmakers Argue Double Patenting Ruling Defies Congress
AbbVie, Merck, Johnson & Johnson, AstraZeneca, Novartis and other big-name pharmaceutical companies are urging the full Federal Circuit to reconsider a patent invalidation that they say placed a judicially made rule...To view the full article, register now.
Already a subscriber? Click here to view full article